cardiovascular patients. Angina pectoris, Acute myocardial infarction, Subsequent myocardial infarction,Certain current complications following acute myocardial infarction, Other acute ischaemic heart diseases, Chronic ischaemic heart disease, Heart failure, Chronic Ischaemic He
Conditions
Interventions
Intervention 1: Control group: Taking 5 cc blood from the patient’s opposite hand vein. Intervention 2: Intervention group: Taking 5 cc blood from the patients’ saline lock.
Control group: Taking 5 cc blood from the patient’s opposite hand vein
Intervention group: Taking 5 cc blood from the patients’ saline lock
Sponsors
Zahedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
34 Years to 69 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: The patient’s age must range from 35 to 70. They are required to do routine tests of CCU based on the physicians’ order. There should be lack of clinical jaundice and lack of massive hemorrhage such as gastro-intestinal tract bleeding. There should exists Stable hemodynamic status and no sign of pregnancy in female patients. Lack of deformity in both upper limbs (as hemodialysis patients have shunts or Fistula or have mastectomy) is required as well. Exclusion criteria: Hematocrit (less than 25% or more than 60%); Anemia (Hemoglobin less than 12 gm/dl in females and less than 14 gm./dl in males; Coagulating disorders such as thrombocytopenia; Not having safe and healthy suitable vein for catheter insertion and Saline lock fixation; Failure in taking blood from saline lock for first time sampling.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| BUN. Timepoint: Taking blood from Saline Lock and immediately from vein. Method of measurement: Laboratory experiment.;CBC. Timepoint: Taking blood from Saline Lock and immediately from vein. Method of measurement: Laboratory experiment.;CRP. Timepoint: Taking blood from Saline Lock and immediately from vein. Method of measurement: Laboratory experiment.;ESR. Timepoint: Taking blood from Saline Lock and immediately from vein. Method of measurement: Laboratory experiment.;Na. Timepoint: Taking blood from Saline Lock and immediately from vein. Method of measurement: Laboratory experiment.;Cr. Timepoint: Taking blood from Saline Lock and immediately from vein. Method of measurement: Laboratory experiment.;K. Timepoint: Taking blood from Saline Lock and immediately from vein. Method of measurement: Laboratory experiment.;TG. Timepoint: Taking blood from Saline Lock and immediately from vein. Method of measurement: Laboratory experiment.;Cholesterol. Timepoint: Taking blood from Saline Lock and immediately from vein. Method of measurement: Laboratory experiment.;FBS. Timepoint: Taking blood from Saline Lock and immediately from vein. Method of measurement: Laboratory experiment.;CPK. Timepoint: Taking blood from Saline Lock and immediately from vein. Method of measurement: Laboratory experiment.;CKmb. Timepoint: Taking blood from Saline Lock and immediately from vein. Method of measurement: Laboratory experiment.;LDH. Timepoint: Taking blood from Saline Lock and immediately from vein. Method of measurement: Laboratory experiment.;PT. Timepoint: Taking blood from Saline Lock and immediately from vein. Method of measurement: Laboratory experiment.;PTT. Timepoint: Taking blood from Saline Lock and immediately from vein. Method of measurement: Laboratory experiment. | — |
Secondary
| Measure | Time frame |
|---|---|
| -. Timepoint: -. Method of measurement: -. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Piashkarmofrad
University of Medical Sciences
Outcome results
None listed